Dentsply Sirona Announces $550 Million Notes Offering

An update from DENTSPLY SIRONA ( (XRAY) ) is now available.

On June 5, 2025, Dentsply Sirona Inc. announced it had entered into an Underwriting Agreement with Goldman Sachs & Co. LLC to issue and sell $550 million of its 8.375% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2055. The net proceeds of approximately $544.5 million from this offering will be used for general corporate purposes, including repaying existing indebtedness. The offering is expected to close on June 12, 2025, subject to customary closing conditions, and is part of the company’s strategy to manage its financial obligations effectively.

The most recent analyst rating on (XRAY) stock is a Hold with a $23.00 price target. To see the full list of analyst forecasts on DENTSPLY SIRONA stock, see the XRAY Stock Forecast page.

Spark’s Take on XRAY Stock

According to Spark, TipRanks’ AI Analyst, XRAY is a Neutral.

DENTSPLY SIRONA’s overall stock score reflects significant financial performance challenges, with declining revenues and negative margins impacting the score. Technical analysis suggests some stabilization, while the earnings call highlighted both operational strengths and market challenges. Valuation remains a concern with a negative P/E ratio, although the dividend yield is a positive factor for some investors.

To see Spark’s full report on XRAY stock, click here.

More about DENTSPLY SIRONA

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with a history of over a century in innovation and service to the dental industry and patients worldwide. The company develops, manufactures, and markets a comprehensive range of dental and oral health products, as well as other consumable medical devices, under a strong portfolio of world-class brands. Its headquarters is located in Charlotte, North Carolina, and its shares are listed on Nasdaq under the symbol XRAY.

Average Trading Volume: 3,200,364

Technical Sentiment Signal: Sell

Current Market Cap: $3.21B

See more insights into XRAY stock on TipRanks’ Stock Analysis page.